19-55852166-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_134444.5(NLRP4):c.86A>T(p.His29Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,609,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_134444.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLRP4 | NM_134444.5 | c.86A>T | p.His29Leu | missense_variant | 2/10 | ENST00000301295.11 | NP_604393.2 | |
NLRP4 | XM_017026344.1 | c.86A>T | p.His29Leu | missense_variant | 1/8 | XP_016881833.1 | ||
NLRP4 | XM_017026345.1 | c.86A>T | p.His29Leu | missense_variant | 1/8 | XP_016881834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLRP4 | ENST00000301295.11 | c.86A>T | p.His29Leu | missense_variant | 2/10 | 1 | NM_134444.5 | ENSP00000301295.4 | ||
NLRP4 | ENST00000587464.1 | c.86A>T | p.His29Leu | missense_variant | 2/3 | 2 | ENSP00000468496.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246696Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133240
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1456878Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 12AN XY: 724616
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at